RORct is a nuclear hormone receptor that has followed an exponential success carrier. Its modest origins as an orphan receptor cloned from human pancreas blossomed within 15 years into a critical regulator of anti-microbial immunity and a major target in the fight against inflammatory pathologies. Here, I review its role as a transcription factor required for the generation of type 3 lymphoid cells, which induce the development of lymphoid tissues, provide resistance of epithelial stem cells to injury, maintain homeostasis with the symbiotic microbiota, orchestrate defense against extracellular microbes, and regulate allergic responses. RORct is also an intriguing molecule that is regulated by the circadian rhythm and includes cholesterol metabolites as ligands. RORct therefore links anti-microbial immunity with circadian rhythms and steroids, the logic of which remains to be understood.
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A BRIEF HISTORY OF RORgt
Two independent lines of research lead to the discovery of RORg and its shorter isoform RORgt. In the first line of research, PCR primers were designed to amplify cDNAs coding for conserved regions of the DNA binding domain of nuclear hormone receptors. This strategy aimed for the cloning of presumably all nuclear receptors expressed in a given tissue or cell line. Using this approach, novel orphan receptors named retinoid Z receptor (RZR)a and RZRb were then identified in umbilical vain endothelial cells 1 and rat brain. 2 In addition, using hybridization cloning with the cDNA of the retinoic acid receptor (RAR)a, retinoic acid related orphan receptor (ROR)a was identified in rat brain and shown to be identical to RZRa. 3 This lead to the identification of the third member of the RZR/ ROR family, RORg, in a cDNA library from human pancreas, and later from mouse muscle, using the degenerate primer approach. 4, 5 Interestingly, melatonin was reported to activate the transcription factor activity of RORa and RORb in cultured cells, [6] [7] [8] suggesting a role for the ROR family of receptors in circadian rhythms.
In the second line of research, in a screen for proteins that confer resistance to TCR-mediated apoptosis, a shorter isoform of RORg was identified by expression cloning of a thymocyte cDNA library in a T cell hybridoma. 9 Although RORg is expressed in a variety of organs, this new isoform was found to be primarily expressed in the thymus and was therefore named RORgt. Mice that lacked the expression of both RORg and RORgt showed increased thymocyte apoptosis. [9] [10] [11] Such mice also had the remarkable phenotype of lacking lymph nodes (LNs) and Peyer's patches (PPs). In knock-in mice in which the Rorc(gt) locus coded for GFP instead of RORgt, but still expressed RORg, it was shown that RORgt is expressed by and is required for the development of fetal lymphoid tissue inducer (LTi) cells, 12 a then enigmatic cell type that colonizes developing lymphoid tissues in the fetus before any other hematopoietic cell type. [13] [14] [15] It was nevertheless the association of RORgt with Th17 cells that shot RORgt to universal fame. In a landmark paper by Dan Cua et al., it was demonstrated that IL-23, rather than IL-12, is the critical cytokine in experimental autoimmune encephalomyelitis (EAE), a mouse model for multiple sclerosis. 16 In a second paper, Cua reported that IL-23 promotes the generation of Th17 cells, the effector cells that drive EAE. 17 On the basis of transcriptome profiles, Th17 cells were found to express high levels of RORgt as compared with Th1 cells, an observation that lead to the demonstration that Th17, like LTi cells, express RORgt and require RORgt for their generation. 18 Two years later, the world of RORgt þ cells expanded again. A population of LTi-like cells was identified that express markers of natural killer (NK) cells, such as NKp46, as well as 1 the signature cytokines IL-17 and IL-22, but do not cluster or induce the development of lymphoid tissues. [19] [20] [21] [22] To keep control of the expanding universe of LTi-like cells, the term ''innate lymphoid cells'' (ILCs) was coined. 23, 24 It was progressively realized that the ILC universe includes ILC1s, ILC2s, and (RORgt þ ) ILC3s, which mirror Th1, Th2, and Th17 cells in the expression of signature transcription factors, surface markers, and effector cytokines. 25 A recent observation brings RORgt back full circle to its original description as a cousin of the melatonin receptors RORa and RORb. [6] [7] [8] RORg is a component of the transcriptional network of peripheral circadian clocks, 26, 27 which regulates the transcription factor Nfil3, which in turn represses the expression of RORgt. 28 Deregulation of the circadian clock thus leads to a deregulation of Th17 cells and increased susceptibility to inflammatory pathology. Finally, and no less intriguing, cholesterol metabolites are natural ligands of RORgt, 29, 30 possibly linking type 3 immunity to the endocrine system and metabolism, even though the biology of these ligands remains to be understood. 14,31,33 LTa 1 b 2 is essential for the development of lymphoid tissues, [34] [35] [36] as it engages LTbR on specialized stroma cells, which in turn induces the expression of adhesion molecules and chemokines that recruit lymphocytes and myeloid cells. 37 After birth, LTi cells cluster in hundreds of so-called cryptopatches (CPs) located between crypts of the intestinal lamina propria. 38, 39 CPs collect B cells to develop into isolated lymphoid follicles (ILFs), which generate mostly T cellindependent IgA þ B cells. [40] [41] [42] Surprisingly, the formation of ILFs from CPs requires bacterial microbiota. 41, 43 Proliferating bacteria release peptidoglycans from their cell wall, which is recognized by the innate receptor NOD-1 in epithelial cells. 44 This unleashes an activation cascade through the release of CCL-20, the activation of the CCR6 þ (the receptor for CCL-20) LTi cells and stroma cells in CPs and the recruitment of B cells. 43, 45 In RORgt-deficient mice, ILFs-like structures still develop. 46 However, these structures are termed tertiary lymphoid tissues, which are induced by chronic inflammation in most organs independently of LTi cells, through the expression of LTa 1 b 2 by subsets of B cells, T cells, or NK cells. 47 Intriguingly, LTi cells are retained in mature (adult) LNs and PPs, and locate in the cortex between B cell follicles. 48 Their functions in this region remains enigmatic, mainly because it has been so far impossible to investigate the consequence of a absence of LTi cells in adult lymphoid tissues, as RORgtdeficient mice lack both.
ILC3s
A population of intestinal lymphoid cells expressing the NK marker NKp46 in mouse and NKp44 in human, was found to co-express RORgt and IL-22. [19] [20] [21] [22] These cells were originally named NK22 cells, but their requirement for RORgt rather than Eomes in development, as well as their cytokine profile, makes them more similar to LTi cells than to NK cells. However, in contrast to LTi cells, NK22 do not cluster in CPs, and therefore, are not involved in the development of LNs, PPs, and ILFs. 49, 50 Rather, NK22 are viewed as more ''regular'' effector cells that patrol the tissue and produce effector cytokines where it matters in terms of defense and injury. 51 Given their common dependence on RORgt and their similar cytokine profiles, LTi cells and NK22 cells were grouped together as ILC3s, whereas lymphoid cells that produce the type 2 cytokines IL-4, IL-5, and IL-13 were grouped as ILC2s, and those that produce IFNg as ILC1s. 23, 24 A difficulty arose when it was found that ILC3s can downregulate RORgt and upregulate T-bet to produce IFNg in a context of intense inflammation. 52 These cells were termed ex-ILC3s. Another form of ILC3 plasticity was found in vitro using human ILC lines. When stimulated through TLR2, such lines expressed IL-5 and IL-13 in addition to IL-22. 53 It remains to be assessed to what extent such plasticity is operational in vivo, underlying for example the rapid response of ILCs to diverse types of tissue perturbations.
The prompt responsiveness of ILCs to infection and injury places them upstream in the immune response. ILC3s are activated by the inducer cytokines IL-1b and IL-23 produced by macrophages and dendritic cells (DCs) typically in response to infection by extracellular bacteria and fungi. Activated ILC3s produce the effectors cytokines IL-17, IL-22, GM-CSF, LTa 3 , and LTa 1 b 2 , which in turn induce the production of antimicrobial peptides by epithelial cells, of neutrophil-recruiting chemokines by stromal cells and epithelial cells, 25, 54 and the activation of B cells. 55, 56 This antigen-independent mode of activation of ILCs is similar to that of memory and ''innate'' T cells, at least in terms of kinetics. 57 It does not require selection and expansion of antigen-specific clones, but rather relies on the expansion of populations. It remains to be understood whether sub-subsets of ILCs exist and specifically expand in reaction to particular infections and injuries, thereby providing a form of immunological memory to challenges, as described for NK cells. ILC3s have a critical role early in the protection to enteropathogens, such as the proteobacteria Citrobacter rodentium, a homolog of the human Escherichia coli intestinal pathogens, 19 to Salmonella enterica, 52 and to rotaviruses, 59 through their production of IL-22. They also mediate containment of bacterial symbionts that live within PPs, 60 and more generally protect from injury-induced inflammation through the containment of symbiotic bacteria. 46, 61 The secretion by ILC3s of IL-22 also has a role in the protection of epithelial cells from apoptosis induced by chemotherapy or irradiation in the intestine and the thymus, [62] [63] [64] as well as in the protection of hepatocytes from inflammation. 65 Intriguingly, ILC3s are relatively resistant to irradiation and chemotherapy, possibly as a consequence of their low turnover. 12, 49, 66 On the other hand, ILC3s and IL-22 are involved in the progression of colon cancer, 67 presumably because they protect epithelial cells from apoptosis through the activation of the transcription factor STAT3. [62] [63] [64] In addition, ILC3s contribute to inflammatory pathology through their capacity to co-express IFNg during Salmonella infection in mouse 52 and in patients suffering from inflammatory bowel disease (IBD). 68, 69 The expression of IL-17 by ILC3s is involved in obesity-associated asthma induced by high fat diet, 70 possibly as a consequence of a loss of containment of the intestinal microbiota and an induction of ILC3s in adipose tissue by incoming bacteria and bacterial compounds. 71 Another surprising feature of ILC3s is their expression of major histocompatibility complex (MHC) class II, 12, 14 as well as of several components of the class II antigen-processing pathway. This feature allows ILC3s to present antigens and repress the activity of specific T cells in the intestine during homeostasis, 72 and to induce T cell activation in the spleen. 73 The relative role of ILC3s, DCs, and macrophages in the MHC class II-restricted activation and regulation of T cells, 74 at least in the intestine and the lymphoid tissues, remains to be measured.
So, ILC3s are pivotal to many processes in mucosal immunity, from the development of lymphoid tissues and the containment of the microbiota, the early immunity to pathogens and the protection of epithelial cells, to the exacerbation of inflammatory pathology and the progression of cancer. Even though ILC3s depend on RORgt for their development, it remains to be determined whether RORgt is also required for their maintenance, an important consideration when targeting RORgt with agonists or antagonists to regulate type 3 immune responses. 75, 76 A recent report shows that a RORgt antagonist leads to the loss of Th17 cells but not of ILC3s. 
THYMOCYTES AND Th17 CELLS
RORgt is required for the survival of immature CD4 þ CD8 þ thymocytes by regulating the level of the anti-apoptotic factor Bcl-x L . 10 In the absence of RORgt, immature thymocytes spend less time at the CD4 þ CD8 þ stage and therefore, recombination of the genes coding for the TCRa chain is biased towards proximal Va to Ja re-arrangements. 78 The thymus of a RORgt-deficient mouse contains half the number of cells found in the thymus of a wild-type animal. 10 In the periphery, control of anti-apoptotic genes by RORgt has not been reported.
Expression of RORgt by T cells remains confined to immature thymocytes, until Th17 cells develop that require RORgt. 18 Naive CD4 þ T cells are induced into the Th17 pathway by IL-1b, 79 IL-23, 17, 80 or the combination of IL-6 and TGFb. [81] [82] [83] IL-23 and IL-6 induce the phosphorylation of STAT3, which in turn induces the expression of RORgt. 84 The characterization of Th17 cells was initially reported in the context of EAE as the cells that are induced by IL-23 to express IL-17 and provoke autoimmunity, 17 as well as in arthritis 85, 86 and IBD. 87, 88 Therefore, RORgt was first perceived as a public enemy that must be targeted to block the progression of autoimmune inflammation. Another line of research nevertheless showed the importance of Th17 cells in mucosal immunity to pathogens and their role in the containment of the microbiota through both the production of IL-17 and IL-22. 89, 90 Caught in the middle of these confusing perceptions, IL-17 and IL-22 have been sometimes described as both pro-and anti-inflammatory, which only reflects the homeostatic or pathologic context in which these cytokines were studied. In contrast, ILC3s, also acting both during intestinal homeostasis and pathology, were first characterized in the context of intestinal homeostasis and thus as primarily ''beneficial'' cells. 39, 43 Nevertheless, the distinctive role of Th17 cells and ILC3s in homeostasis, defense and pathology has been difficult to pull apart, as models to ablate Th17 cells or ILC3s, individually, have to be improved. 19, 60 On the basis of their innate versus adaptive nature, early responses against pathogens have generally been ''assigned'' to ILC3s, whereas chronic responses, such as autoimmune inflammation, have been assigned to Th17 cells.
The mechanisms by which microbes induce Th17 cells, and more generally type 3 immune responses, remain a hard nut to crack. Whereas it is clear that IL-1b and IL-23 have a central role in the cascade of events that lead to the generation of Th17 cells, 17, 79, 80, 91 the signals that induce IL-23 are not known. It has been shown that ATP, produced by bacteria, activates a subset of intestinal lamina propria DCs through the P2X and P2Y receptors to produce IL-23, 92 but this mechanism remains to be validated in the context of bacteria that adhere to epithelial cells, such as segmented filamentous bacteria 93, 94 and pathogenic strains of E. coli, which efficiently induce the generation of Th17 cells. 95 The pathway by which these adherent bacteria induce Th17 cells remains unknown.
TYPE 3 TREGs
FoxP3 is the signature transcription factor for regulatory T (Treg) cells. Therefore, it came as a surprise that a significant proportion of intestinal FoxP3 þ T cells also expresses RORgt. 96 It was suggested that RORgt þ FoxP3 þ cells are not Tregs, but rather precursor T cells that express both transcription factors until expression of one is promoted over the other to generate Tregs or Th17 cells. 83 This hypothesis was derived from the observation that 25% of intestinal Th17 cells had expressed FoxP3 at some stage of their development, as determined by genetic fate mapping of FoxP3 þ cells. It was also suggested that Tregs acquire characteristics of effectors cells, induced by the inflammatory state of the tissue. 97 For example, colitis induces the expression of IL-23 by macrophages and DCs, which in turn induces the expression of RORgt in developing effector T cells as well as in Tregs. This leads to the expression of the chemokine receptor CCR6 on both mature Th17 and RORgt þ Tregs, 96 and thus co-localization of both the effector and the regulator cells to augment the efficacy of immune regulation. 98 Furthermore, a small proportion of RORgt þ Tregs was found to be ''perverted'' into genuine effector cells, induced by chronic inflammation into the expression of IL-17. 99 Nevertheless, the majority of RORgt þ Tregs produces IL-10 at levels that exceed the levels produced by other subsets of Tregs, and express high levels of other attributes of Tregs, such as ICOS, CTLA-4, CD39, and CD73, 100 and exert regulatory functions in vitro and in vivo. 96, 98 Moreover, IL-10-producing RORgt þ Tregs markedly expand during intestinal and lung inflammation, presumably to avoid exponential growth of the inflammation. 96 Nevertheless, it is possible that the phenomenon of Treg ''perversion'' expands during chronic long-term inflammation, conditions found in the intestine of IBD and colon cancer patients 99 -but rarely obtained in mouse models. Recently, it was demonstrated that microbiota-and antigeninduced Tregs express RORgt, whereas microbiota-independent Tregs include a subset expressing Gata3. [100] [101] [102] [103] The generation of RORgt þ Tregs is dependent on antigen presentation by DCs and macrophages, as well as on the activation of STAT3. 100 Surprisingly, the ''pro-Th17'' cytokines IL-6 and IL-23, rather than IL-10, activate STAT3 for the generation of RORgt þ Tregs. The eventual lineage choice to generate RORgt þ Tregs instead of Th17 cells is dependent on the metabolism of vitamin A into retinoic acid (RA), as an absence of vitamin A, or the inhibition of the RA receptor, tips the balance in favor of Th17 cells. 100 This suggests that the normal metabolism of vitamin A by DCs, stromal cells, and neurons, rather than microbes, determines the balance between RORgt þ Tregs and Th17, or in other words, between anti-and pro-inflammatory (type 3) responses. I, therefore, propose that RA, required in many physiological processes, is a ''normo-signal'' used by the immune system to monitor the health state of a tissue. In the context of tissue damage, upon infection or injury, the production of RA is decreased and the balance between RORgt þ Tregs and Th17 cells is shifted in favor of Th17 cells. During homeostasis in the intestine, this balance is regulated to the level of effector type 3 immunity required to contain the symbiotic microbiota.
In one study, the absence of RORgt þ Tregs lead to the increase in Th1 and Th17 cells, and the exacerbation of colitis. 101 However, in another study, RORgt þ Tregs were not found to control Th1 and Th17 cells, but rather Th2 cells. 100 It was proposed that bacteria induce type 3 responses, mediated by Th17 cells and RORgt þ Tregs, which collectively repress competing type 1 or type 2 responses, a phenomenon described by the equilibrium model of immunity. 104 As a consequence, in mice that lack RORgt þ Tregs or Th17 cells, anti-helminth responses are increased and allergic inflammation is exacerbated. Thus microbiota regulates allergy through the induction of type 3 responses. 100 The exacerbated Th17 responses observed in the absence of RORgt þ Tregs, reported in the first study, 101 may be the consequence of an intestinal microbiota that is more potently inducing effector type 3 responses than in the second study. 100 The developmental origin of RORgt þ Tregs remains debated and is difficult to address. Do they derive from Th17 cells, RORgt À FoxP3 þ Tregs, or naïve T cells? Genetic fate mapping, using Foxp3 or Rorc(gt), cannot be conclusive, as FoxP3 is continuously expressed in the Treg lineage, whereas RORgt is already expressed by immature CD4 þ CD8 þ T cells in the thymus. 39 Resolution of the differentiation pathway of RORgt þ Tregs requires the transfer in vivo of single T cells, or individual T-cell barcoding.
OTHER CELLS EXPRESSING RORgt
RORgt is expressed exclusively by lymphoid cells. Or so we thought. Populations of bone marrow and human blood neutrophils express RORgt, as well as IL-17 upon stimulation with IL-6 and IL-23. 105 A similar subset of RORgt þ neutrophils was identified in mice that expresses IL-17 upon Aspergillus fumigatus infection of the lungs. 106 These observations are reminiscent of older data showing that lipopolysaccharides (LPS) induce lung neutrophilia, the recruitment of which is induced by CXC chemokines produced by stromal and epithelial cells. These chemokines are in turn induced by IL-17 produced by neutrophils and T cells. 107 
RORgt AS A MOLECULE
The natural ligand for RORgt has remained elusive for long ( Figure 2) . The related RORa was co-crystallized with cholesterol and cholesterol sulfate. 108 Recently, it was found that cholesterol biosynthetic intermediates, such as oxysterols, are involved in the function of RORgt during the development of LNs and the differentiation of Th17 cells and IL-17 þ Tgd cells. 29, 109 These sterols are likely to be endogenous metabolites, rather than compounds derived from the microbiota, as LNs and ILC3s develop in germ free animals. Interestingly, 7a,27-hydroxycholesterol, is both a ligand for RORgt and EBI2, a G protein-coupled receptor involved in the positioning of activated B cells in LNs. The functional link between RORgt and EBI2 remains unexplored. 30 Synthetic inverse agonists of RORgt have been identified that derive from liver X receptor (LXR) agonists 75 or sterols such as digoxin 76 and ursolic acid. 110, 111 Such compounds trigger intense interests from the pharmaceutic industry as drugs to block type 3 responses during autoimmunity and IBD. Evidently, given the multiple cells and pathways that depend on RORgt, including the containment of the intestinal microbiota and the regulation of competing immune responses such as allergic responses, such a strategy may cause important collateral damage, or be inefficient in the intestine. 46, 100 It is possible that for similar reasons, anti-IL-23 treatment is inefficient or even deleterious in the context of IBD, even though it is very efficient in the context of skin disease. 112 Interestingly, it appears that Th17 cells are more sensitive to transient RORgt inhibition than ILC3s, 77 indicating that partial blockage of type 3 responses can be achieved with RORgt inhibitors that may preserve the activity of ILC3s and some level of microbial containment. Regulation of RORgt also occurs at the protein-protein level. Itch is an E3 ubiquitin ligase that binds RORgt and targets it for ubiquitination and degradation. 113 In the absence of Itch, mice develop IL-17-dependent intestinal inflammation and tumorigenesis. Nitric oxide (NO) also regulates the activity of RORgt through nitration of tyrosine residues. 114 As a consequence, iNOS-deficient mice develop enhanced Th17 differentiation. At the transcription factor level, FoxP3 binds directly to RORgt and appears to impose its anti-inflammatory program in RORgt þ Tregs over the pro-inflammatory program induced by RORgt. 83, 96 Gata3, the signature transcription factor of type 2 responses, directly binds to and inhibits the Rorc promoter. 103 Finally, T-bet, the signature transcription factor of type 1 responses, prevents Runx1 to mediate transactivation of Rorc. 115 An interesting twist in the regulation of RORgt expression involves Nfil3. This basic leucine zipper transcription factor is required for the development of NK cells, 116 as well as more generally for the development of ILCs. [117] [118] [119] Nfil3 is negatively regulated by the clock protein Rev-Erba, and in turn, negatively regulates expression of RORgt by directly binding to the Rorc promoter. 28 As a consequence, the expression of RORgt, and the amplitude of type 3 responses, is regulated by the circadian clock, and disruption of the circadian rhythm leads to increased susceptibility to type 3 inflammatory pathology.
RORgt AND RORg
RORg directly regulates the expression of clock genes through binding to the promoter of Cry1, Bmal1, Rev-Erba, and also Nfil3. 120 Thus, RORg regulates clock genes, and one of those clock genes, Nfil3, regulates RORgt. 28 However, RORg and RORgt are not usually co-expressed in the same type of cells. Whereas RORgt is expressed in lymphoid cells (and neutrophils) exclusively, RORg is not expressed in hematopoietic cells, but in many other types of parenchymal cells, such as hepatocytes and muscle cells. 9 Therefore, it is possible that RORg and RORgt have similar biology in different cells, both connected to circadian clocks and oxysterol ligands, 29, 109 but have different functions through the regulation of distinct set of tissue-specific genes.
Interestingly, the other members of the ROR family, RORa and RORb, also have important roles in the circadian rhythms, as both RORa-deficient mice and RORb-deficient mice show alterations in circadian oscillations. 121 
CONCLUDING REMARKS
RORgt has turned out to be an extraordinary nuclear receptor and transcription factor, which controls type 3 immunity, a critical branch of immune responses that contains the symbiotic microbiota at mucosal surfaces and fights bacterial and fungal pathogens, but also leads to autoimmunity and cancer. The links between RORgt, oxysterols, and clock genes makes RORgt a potential node connecting immunity with metabolism and circadian rhythms. The biology of RORgt blossoms at an exciting time as immunology expands into a more transversal field of research connecting different physiological systems.
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